CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 78993 | LVS EN ISO 10993-23:2021/A1:2025 | Biological evaluation of medical devices - Part 23: Tests for irritation - Amendment 1: Additional in vitro reconstructed human epidermis models (ISO 10993-23:2021/Amd 1:2025) | |
| 78994 | EN ISO 10993-17:2023/FprA1 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/FDAM 1:2025) | Izstrādē |
| 79217 | EN ISO 10993-7:2008/prA11 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals | Izstrādē |
| 79539 | EN ISO 14155:2020/A11:2024 | Clinical investigation of medical devices for human subjects - Good clinical practice | Standarts spēkā |
| 79539 | LVS EN ISO 14155:2020/A11:2024 | Clinical investigation of medical devices for human subjects - Good clinical practice | Standarts spēkā |
| 80820 | EN ISO 10993-5:2009/A11:2025 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 80820 | LVS EN ISO 10993-5:2009/A11:2025 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 80886 | prEN ISO 22442-3 rev | Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents | Izstrādē |
| 80887 | prEN ISO 10993-4 rev | Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood | Izstrādē |
| 80888 | prEN ISO 10993-13 rev | Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices | Izstrādē |
Displaying 181-190 of 192 results.